# Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR

> **NCT00240682** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier of Chartres** · enrollment: 37 (actual)

## Conditions studied

- Skin Diseases
- Carcinoma, Squamous Cell

## Interventions

- **DRUG:** cetuximab

## Key facts

- **NCT ID:** NCT00240682
- **Lead sponsor:** Centre Hospitalier of Chartres
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2009-04
- **Final completion:** 2009-06
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2012-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240682, "Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00240682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*